Program Overview
This continuing medical education program is derived from material presented in an AcademicCME-sponsored symposium held in conjunction with the 2020 AAP Virtual National Conference & Exhibition. This continuing medical education program will highlight therapeutic advances for the management of patients with atopic dermatitis, focusing primarily on the pediatric population. The expert faculty, chaired by Dr. Lawrence F. Eichenfield, will first cover the immunopathology and characteristics of disease, including best practices for severity scoring to accurately assess pediatric patients. Following, recent clinical trial data for the treatment of atopic dermatitis will be reviewed and clinical relevance debated in an interactive panel format. The faculty will discuss optimal management strategies, including both guideline-driven and holistic approaches for improving patient outcomes and quality of life. This interactive, case-based education will update clinicians on current practices to better treat and manage pediatric patients with atopic dermatitis.
Target Audience
General pediatricians, internal medicine, and family physicians who are involved in the care and treatment of patients with atopic dermatitis.
Learning Objective
- Review the disease characteristics, diagnostics, immunopathology, and severity scoring to accurately assess pediatric patients with atopic dermatitis.
- Summarize recent clinical trial data and therapeutic target mechanisms of action for the treatment of atopic dermatitis.
- Discuss guideline-driven pharmacotherapeutic treatment strategies and the holistic approach to improve outcomes in pediatric patients with atopic dermatitis.
Chair
Lawrence F. Eichenfield, MD
Professor of Dermatology and Pediatrics
Vice Chair, Department of Dermatology
University of California, San Diego School of Medicine
Chief, Pediatric and Adolescent Dermatology
Rady Children’s Hospital
San Diego, California
Faculty
Bob Geng, MD
Assistant Clinical Professor, Medicine
Rady Children’s Hospital
San Diego, California
Wynnis Tom, MD
Associate Clinical Professor
Department of Pediatrics and Medicine
University of California, San Diego
Rady Children’s Hospital
San Diego, California
Disclosures of Conflict of Interest
It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
| Faculty | Relationship Identified With: |
| Lawrence F. Eichenfield, MD | Consultant/Advisor: Almirall; Anacor Pharmaceuticals Inc.; Dermavant Sciences, Inc.; Dermira, Inc.; DS Biopharma Limited; Eli Lilly and Company; Forte Pharma; Galderma Laboratories; Incyte Corporation; Leo Pharma; L’Oreal; Matrisys Bioscience; Novartis Pharmaceuticals Corporation; Ortho Dermatologics, Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc.; Regeneron; Sanofi Genzyme; Valeant; Verrica Data Safety Monitoring Board: Asana Biosciences; Glenmark Pharmaceuticals; Ichnos Sciences Investigator: AbbVie Inc.; Leo Pharma; Regeneron; Sanofi Genzyme Speaker’s Bureau: Ortho Dermatologics, Inc.; Valeant |
| Bob Geng, MD | Consultant/Advisor: Pfizer; Regeneron; Sanofi Speaker’s Bureau: Regeneron; Sanofi |
| Wynnis Tom, MD | Grant/Research Support: Incyte; Janssen; Pfizer; Regeneron Data Safety Monitoring Board: Leo Pharma |
Planners and Peer Reviewers
Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC; and Chelsey Benedek hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.
Accreditation Statement
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. This activity was planned by and for the healthcare team.
Credit Designation Statements
AcademicCME designates this live material for a maximum of 1.50 AMA PRA Category 1 Credits TM.
Participants should claim only the credit commensurate with the extent of their participation in the activity.
Financial Support
This activity has been supported by an independent educational grant from Pfizer, Inc.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Pfizer, Inc. do not recommend the use of any agent outside of the labeled indications.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
In order to claim credit, participants must complete the following:
- Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
- Complete the Pre-Activity Questions
- Read or Review the activity content.
- Complete the Post-Activity Test Questions and Evaluation.
- Learners who receive a grade of 70% or better on the Post-Activity Test Questions and complete the Evaluation will receive appropriate credit as indicated (CME, CNE, and/or CPE credit).
- CPE credit will be posted to the learner’s CPE Monitor profile within 60 days of completion.
- CME and CNE credit will be issued appropriate certificate of completion.
- Others may request a “certificate of completion”.
- Learners should claim only the credit commensurate with the extent of their participation in the activity.
CE Inquiries/Special Needs
For all CE inquiries or special needs, please contact [email protected].
